TD Cowen Maintains Buy on GeneDx Hldgs, Raises Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Dan Brennan maintains a Buy rating on GeneDx Holdings (NASDAQ:WGS) and raises the price target from $46 to $50.
July 31, 2024 | 7:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Dan Brennan maintains a Buy rating on GeneDx Holdings and raises the price target from $46 to $50.
The Buy rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100